|
||
| |||||||
|
ChemOvation and Cancer Research Technology have entered into a collaborative agreement in the field of target validation drug discovery 27th May 2003 Under the terms of the collaboration, ChemOvation and CRT scientists will work closely together in an interdisciplinary team to fully exploit the integration of biology and chemistry. Financial details were not disclosed. ChemOvation
will support CRT by providing computational and medicinal chemistry
services on CRT’s biological targets. ChemOvation will also offer highly
focused chemical libraries specific to the therapeutic target. Dr
Keith Menear, Director of Chemistry and Operations, ChemOvation Ltd
commented, "This collaboration provides an exciting opportunity to
evaluate a target validation on CRT’s target. We are delighted to have
the opportunity to work with Cancer Research Technology in our quest to
provide small molecular drug candidates against this important protein
target. We believe this collaboration with CRT will enable ChemOvation and
CRT to accelerate research against this important therapeutic
target". ChemOvation
Ltd ChemOvation
is a leading provider of drug discovery services to the pharmaceutical and
biotechnology sector. It provides a fully integrated service specialising
in: ·
Medicinal chemistry ·
Organic chemistry ·
Computational chemistry ·
Screening · ADME and early Toxicology ChemOvation
offers clients a wealth of scientific knowledge and expertise to ensure
success in their drug discovery projects. Whether
it’s for lead optimisation, hit expansion or custom synthesis,
ChemOvation provides the complete outsourcing solution for drug discovery
projects. For
more information, please visit www.chemovation.com
or contact Dr
Keith Menear ChemOvation
Ltd Foundry
Lane Horsham West
Sussex RH13
5PX Phone:
+44 (0) 1403 248844 Fax:
+44 (0) 1403 248855 Email:
keith.menear@chemovation.com
Cancer
Research Technology Limited
Cancer Research Technology (CRT) is a specialist oncology-focused technology transfer and development company that aims to advance new discoveries in cancer research for the benefit of cancer patients. CRT is owned by the charity, Cancer Research UK. CRT works closely with cancer researchers and their institutes to protect the intellectual property arising from their research and to establish links with commercial partners. CRT facilitates the discovery, development and marketing of new cancer therapeutics and diagnostics. Further
information about Cancer Research Technology can be obtained from:
Cancer
Research Technology Limited Sardinia
House Sardinia
Street London
WC2A 3NL United
Kingdom Tel:
+44 (0)20 7269 3640 Fax:
+44 (0)20 7269 3641 |
|
| ||||||||